An analysis suggests that about 1 in 10 people in the US with ADHD who use Adderall or similar drugs have been affected by a shortage, causing a significant drop in prescription fill rates. The shortage has been ongoing since mid-October 2022, impacting both adults and children with ADHD. The shortage has raised concerns about the access to necessary medication and its potential negative impacts on individuals with ADHD.
Key Points
Prescription fill rates for amphetamine/dextroamphetamine medications dropped significantly following the shortage announcement
Shortage has affected both adults and children with ADHD, impacting their ability to manage symptoms
Concerns raised about the potential negative consequences of inconsistent access to medication for individuals with ADHD
Pros
Increased awareness of the impact of medication shortages on individuals with ADHD
Highlighting the importance of consistent access to medication for managing ADHD symptoms
Cons
Negative effects on individuals with ADHD who rely on Adderall for symptom management
Potential risks and challenges faced by those unable to access necessary medication